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S86Objectives: This study assessed comparative effectiveness of minimally invasive versus traditional sternotomy
mitral valve surgery in elderly patients.
Methods: From January 1, 2000, to December 31, 2008, 1005 patients underwent isolated mitral valve surgery
at our institution. Patients 75-years-old were included in analysis (sternotomy, n ¼ 105; minimally invasive,
n¼ 70). Clinical outcomes included bypass and crossclamp time, length of hospitalization, morbidity, and mor-
tality. To assess resource use, total hospital costs and discharge location were analyzed. Three standardized in-
patient functional status outcomes were also assessed.
Results: The minimally invasive approach was associated with a 9.2-minute longer crossclamp time (P¼ .037)
and a 25.2-minute longer bypass time (P<.001). Minimally invasive surgery was associated with a 3.1-day
shorter hospitalization (P ¼ .033). There were no significant differences in rate of major postoperative compli-
cations (P ¼ .085) or long-term survival (P ¼ .60). Minimally invasive approach was associated with a $6721
lower median cost of hospitalization (P¼ .007) and more common discharge to home, routinely or with a health
aide, rather than to rehabilitation (P ¼ .021). Minimally invasive patients achieved faster rates of independent
ambulation (P ¼ .039) and independent sit-to-stand activity (P ¼ .003), although there were no differences in
time to independent stair climbing (P ¼ .31).
Conclusions:Among elderly patients, minimally invasive mitral valve surgery is associated with slightly longer
crossclamp and bypass times but with equivalent morbidity and mortality and shorter hospitalization, decreased
resource use, and improved postoperative functional status. (J Thorac Cardiovasc Surg 2012;143:S86-90)Since the first descriptions of minimally invasive mitral
valve surgery (MIMVS) in the mid 1990s, there has been
a growing body literature on the safety and efficacy of min-
imally invasive approaches for both mitral valve repair and
replacement.1 Some of the reported benefits of a minimal
access approach include decreased surgical trauma, im-
proved cosmesis, decreased postoperative pain, and reduced
duration of hospitalization.2
Despite improvements in surgical technique and cannula-
tion methods, the potential advantages of MIMVS have of-
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The Journal of Thoracic and Cardiovascular Surgmitral valve surgery performed under limited exposure,
the learning curve associated with minimally invasive ap-
proaches, and the potential for prolonged operative times.
Although no prospective studies have compared MIMVS
to the traditional sternotomy approach, several retrospective
analyses have shown that the potential benefits of MIMVS
can be achievedwithout compromise to the efficacy of valve
repair and without increased morbidity or mortality.3,4 One
of the major limitations of such analyses, however, is that
often significant differences in baseline risk exist between
minimally invasive and sternotomy groups, and thus
statistical adjustments are required to compare groups,
which results in inherent bias.5 In most analyses, patients
undergoing MIMVS are at lower risk, are younger, have
a lower body mass index, and have fewer comorbidities.
As the popularity of MIMVS has grown, the technique
has been expanded to patient subgroups previously consid-
ered at too high risk for a minimally invasive approach. Cur-
rently, there is a paucity of literature on minimally invasive
cardiac surgery in the elderly population. The goal of this
analysis was therefore to assess the comparative effective-
ness of a minimally invasive versus a traditional sternotomy
approach for mitral valve surgery in elderly patients.
MATERIALS AND METHODS
Study Population
After institutional review board approval was obtained, data on all iso-
lated mitral valve operations performed at our institution from January 1,ery c April 2012
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CPB ¼ cardiopulmonary bypass
MIMVS ¼ minimally invasive mitral valve surgery
2000, to December 31, 2008 (n ¼ 1005) were retrospectively reviewed.
Isolated mitral valve surgery was defined as any mitral valve repair or re-
placement performed in the absence of a major concomitant procedure,
such as coronary artery bypass grafting or other valve surgery. Patients
younger than 75 years and those undergoing reoperative surgery were ex-
cluded from the analysis for a net effective study cohort of 175 patients. A
traditional median sternotomy approach was used in 105 patients (60%),
and a minimally invasive approach was used in 70 patients (40%).
Operative Technique
Although MIMVS can be defined broadly according to the Society of
Thoracic Surgeons database guidelines as anymitral valve repair or replace-
ment performed through an incision other than a full median sternotomy, in
our analysis allMIMVScaseswere performed through a rightminithoracot-
omy. Our operative approach for MIMVS performed through a minithora-
cotomy has been described previously elsewhere.6 Of note, aortic
cannulationwasmost commonly performed in a central fashion, and venous
drainage was most commonly achieved through a percutaneous femoral
vein approach with single multistage venous cannulation. Central aortic
cannulation was performed through the initial thoracotomy incision, and
a transthoracic aortic crossclamp (Chitwood clamp; Scanlan International
Inc,Minneapolis,Minn)was passed through a stabwound in the right axilla.
Outcome Measures
Major clinical outcome measures included cardiopulmonary bypass
(CPB) time, crossclamp time, duration of hospitalization, major
in-hospital complications, (intubation>72 hours, renal failure, sepsis, re-
operation for bleeding, stroke, and gastrointestinal bleeding), and both
short- and long-term survivals. To assess resource use, data were also col-
lected on total hospital costs, direct costs, indirect costs, number of read-
missions within 1 year of surgery, and discharge location. Hospital cost
data were obtained from our institutional finance department decision sup-
port system (Eclipsys Transition System Incorporated, Atlanta, Ga), which
provides audited clinical, financial, and operational data. The reported cost
data represent actual resource costs to the hospital for services rendered,
rather than billed charges. Finally, to assess the effect of incision type on
functional status, data on time to independent sit-to-stand, time to indepen-
dent ambulation, and time to independent stair climbing were gathered
from standardized computer-entry inpatient physical therapy forms.
Statistical Analysis
Continuous variables are reported as mean SE and median values and
were compared with the Student t test and Wilcoxon rank sum test, respec-
tively. Categoric variables are reported as percentages and were compared
with the c2 test or Fisher’s exact test as appropriate. Long-term survival,
freedom from reoperation, and time to independent physical therapy mile-
stones were assessed with the Kaplan–Meier method and compared with
the log-rank test. Survival data were obtained from the Social Security
Death Index and provided through January 1, 2010. All reported P values
are two-sided. All statistical analyses were performed with the Stata 11 sta-
tistical software package (StataCorp LP, College Station, Tex).
RESULTS
Study Population
Between January 1, 2000, and December 31, 2008, a total
of 175 patients at least 75-years-old underwent isolatedThe Journal of Thoracic and Carmitral valve surgery at our institution (sternotomy, n ¼
105, 60%; MIMVS, n ¼ 70, 40%). Baseline demographic
characteristics are summarized in Table 1. Among 13 demo-
graphic variables, there were no significant differences in
baseline risk between groups. There was no difference in
the proportion of mitral repairs versus replacements be-
tween groups (P ¼ .753), and repair was more common
than replacement in both sternotomy (59.1%, n ¼ 62) and
MIMVS (62.9%, n ¼ 44) groups. Most patients in each
group had mitral regurgitation rather than stenosis (sternot-
omy, n ¼ 92, 87.6%; MIMVS, n ¼ 59, 84.3%; P ¼ .741).
Valve disease etiologies are summarized in Table 1, and
there was no significant difference between groups (P ¼
.345). Most patients had degenerative mitral valve disease
(sternotomy, n¼ 73, 69.5%; MIMVS, n¼ 43, 61.4%); pos-
terior leaflet prolapse was most common in both groups. Of
note, among patients with degenerative disease, there was
no significant difference in the repair rate between groups
(sternotomy, n ¼ 43, 58.9%; MIMVS, n ¼ 23, 53.5%;
P ¼ .70). There were no conversions to a median sternot-
omy approach in the MIMVS group.
Clinical Outcomes
With regard to intraoperative measures, crossclamp time
was 9.2  2.4 minutes longer (sternotomy, 75.2  2.4 min-
utes; MIMVS, 84.4  4.0 minutes; P ¼ .037), and CPB
time was 25.2  5.7 minutes longer (sternotomy, 110.4 
3.0 minutes; MIMVS, 135.7  5.3 minutes; P< .001) in
the MIMVS group. The MIMVS group had a 3.1  1.4
days shorter mean duration of hospitalization (sternotomy,
11.7  1.1 days; MIMVS, 8.7  0.72 days; P ¼ .033).
The median duration of hospitalization was 1 day shorter
in the MIMVS group (sternotomy, 9 days; MIMVS, 8
days; P ¼ .038). There was no significant difference in the
overall rate of major postoperative complications between
groups (P ¼ .085; Table 1). There was no difference be-
tween groups in survivals at 30 days (P ¼ .188) and at 1
year (P ¼ .902; Table 1). Also, there was no difference in
Kaplan-Meier survival (P¼ .60). The mean duration of sur-
vival follow-up was 3.8  2.4 years.
Resource Use
Patients undergoing MIMVS had a $14,391  $5782
lower mean cost of hospitalization (sternotomy, $60,289
 $4843; MIMVS, $45,897  $2586; P ¼ .014). Patients
undergoing MIMVS also had a significantly lower median
cost of hospitalization by $6721 (sternotomy, $43,790;
MIMVS, $37,069; P¼ .007). The mean difference in direct
cost between groups was $9182  $3804 (sternotomy,
$36,387  $3194; MIMVS, $27,205  $1654; P ¼ .017),
and the mean difference in indirect cost was $5372 
$2544 (sternotomy, $24,065  $2027; MIMVS, $18,692
 $1378; P¼ .036). There was a significant association be-
tween incision type and discharge location (P¼ .021), withdiovascular Surgery c Volume 143, Number 4S S87
TABLE 1. Baseline characteristics and major postoperative outcomes
Sternotomy
(n ¼ 105)
Minimally
invasive
(n ¼ 70)
P
value
Baseline variables
Age (y, mean  SE) 79.4  3.9 78.6  3.3 .123
Male sex (no.) 70 (66.7%) 43 (61.4%) .478
Body mass index
(kg/m2, mean  SE)
24.5  0.4 24.0  0.5 .451
Ejection fraction
(%, mean  SE)
50.7%  1.2% 51.9%  1.2% .511
Serum creatinine
(mg/dL, mean  SE)
1.1  0.04 1.0  0.04 .319
COPD (no.) 13 (12.4%) 4 (5.7%) .145
Diabetes (no.) 7 (6.7%) 5 (7.1%) .903
Current CHF (no.) 39 (37.1%) 18 (25.7%) .114
Renal failure (no.) 2 (1.9%) 0 (0%) .245
Cerebrovascular
accident (no.)
9 (8.6%) 3 (4.3%) .216
Immune system
deficiency (no.)
7 (6.7%) 4 (5.7%) .799
Peripheral vascular
disease (no.)
2 (1.9%) 2 (2.9%) .680
Smoker (no.) 20 (19.1%) 22 (31.4%) .060
Valve disease etiology (no.) .345
Degenerative 73 (69.5%) 43 (61.4%)
Dilated cardiomyopathy 6 (5.7%) 3 (4.3%)
Endocarditis 4 (3.8%) 3 (4.3%)
Ischemic 2 (1.9%) 6 (8.6%)
Rheumatic 4 (3.8%) 5 (7.1%)
Calcific 16 (15.2%) 10 (14.3%)
Outcomes
Crossclamp time
(min, mean  SE)
75.2  2.4 84.4  4.0 .0374
Bypass time (min,
mean  SE)
110.4  3.0 135.7  5.3 <.001
Hospitalization
(d, mean  SE)
11.7  1.1 8.7  0.72 .033
Total hospital costs (US$,
mean  SE)
$60,289  $4843 $45,897  $2586 .014
Morbidity (no.)
Intubation>72 h 14 (13.3%) 7 (10%) .506
Renal failure 6 (5.7%) 1 (1.4%) .156
Sepsis 1 (0.95%) 2 (2.9%) .342
Reoperation for
bleeding
5 (4.8%) 0 (0%) .064
Stroke 7 (6.7%) 2 (2.9%) .264
Gastrointestinal
bleeding
1 (0.95%) 2 (2.9%) .342
Mortality (no.)
30-d 3 (2.8%) 5 (7.1%) .188
1-y 11 (10.6%) 7 (10%) .902
COPD, Chronic obstructive pulmonary disease; CHF, congestive heart failure.
Technical Considerations Iribarne et almost patients undergoing MIMVS discharged home rou-
tinely or with a home health aide (sternotomy, 58.2%;
MIMVS, 78.1%) and significantly more of thoseS88 The Journal of Thoracic and Cardiovascular Surgundergoing sternotomy discharged to a rehabilitation facil-
ity (sternotomy, 41.7%; MIMVS, 21.8%). There was no
difference in the rate of readmissions at 1 year between
groups (P ¼ .542).
Functional Status
There was no significant difference in time to first phys-
ical therapy visit between the MIMVS and sternotomy
groups (P¼.14). A time-to-event comparison of the 3 major
functional status outcomes is summarized in Figure 1. Pa-
tients in the MIMVS group achieved faster rates of indepen-
dent ambulation (P ¼ .039) and independent sit-to-stand
activity (P ¼ .003); however, there was no difference in
time to independent stair climbing (P ¼ .31).
DISCUSSION
Elderly persons are among the fastest growing segments
of the population in the United States, and recent projec-
tions indicate that during the next 50 years the number of
individuals older than 75 years will quadruple.7 Data from
the Framingham Heart Study have demonstrated an in-
crease in prevalence of moderate mitral regurgitation from
2.4% among patients between the ages of 60 and 69 years
to 11.2% among patients between the ages of 70 and 83
years.8 Previous studies have demonstrated that cardiac sur-
gery can be performed on elderly patients with higher, albeit
improving, perioperative morbidity and mortality; however,
the increase in prevalence of this population demands inno-
vative approaches that not only address perioperative risk
but also postoperative resource use and functional status.9
MIMVS has grown in popularity during the past decade,
and with improvements in technology and surgical tech-
nique, minimally invasive surgery has been expanded to pa-
tient subgroups previously not considered candidates for
this approach.10 There is a paucity of literature on outcomes
of MIMVS in the elderly population. In this analysis, we
have demonstrated that MIMVS can be performed safely
in patients at least 75 years old. Although the minimally in-
vasive approach was associated with slightly longer CPB
and crossclamp times than was the conventional sternotomy
approach, there were no significant differences in postoper-
ative morbidity and mortality. Importantly, patients under-
going MIMVS had approximate 3 days shorter mean and
1 day shorter median durations of hospitalization, a finding
that has important implications for resource use.
There were significant reductions in both mean and me-
dian costs of hospitalization associated with the minimally
invasive approach, a finding that correlates with the ob-
served difference in duration of hospitalization found be-
tween the groups. Similar differences were also observed
in mean direct and indirect costs. Because of the right-
skewed distribution of costs, the median difference in total
hospital costs of $6721 rather than the mean difference most
likely represents the true cost savings. Most of the patientsery c April 2012
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FIGURE 1. Kaplan-Meier estimates stratified byminimally invasive (MI) versus sternotomy (ST) approach. A, Time to independent ambulation; B, time to
independent stair climbing; C, time to independent sit-to-stand activity.
Iribarne et al Technical Considerationsundergoing MIMVS were also discharged home without
services or with a home health aide, as opposed to being dis-
charged to a rehabilitation center, demonstrating the poten-
tial for significant future cost savings associated with the
minimally invasive approach. Moreover, there were no dif-
ferences in readmission rates at 1 year between groups. Of
note, patients did not undergo any specific preoperative im-
aging studies to define eligibility for MIMVS, demonstrat-
ing that such imaging studies, which increase resource use,
may not be routinely necessary for MIMVS.
Decisions for discharge location are most often based on
a patient’s postoperative functional status. At our institution,
all patients receive inpatient physical therapy after surgery,
and progress is recorded in standardized computer-entry
forms. Patients undergoing MIMVS had faster rates for
both time to independent ambulation and time to indepen-
dent sit-to-stand activity. The observed shorter duration of
hospitalization in that group thus may be due in part to faster
inpatient physical rehabilitation, which translated into ear-
lier discharge home. To date, no studies have assessed differ-
ences in postoperative functional status by incision type;
however, our findings highlight a potential etiology forThe Journal of Thoracic and Carboth the observed reduction in duration of hospitalization
and the improved discharge location.
Limitations
There are several limitations to our analysis. First, our
study is retrospective and subject to multiple potential
biases. Although there was no difference in 13 baseline vari-
ables, other unrecorded differences may exist between
groups, and selection bias cannot be completely eliminated.
At our institution, the decision to pursue a minimally inva-
sive approach involves an overall assessment of the feasibil-
ity and safety of such an approach according to the patient’s
preoperative risk. MIMVS is particularly challenging, for
example, in treating patients with severe chronic obstructive
pulmonary disease, elevated body mass index, and previous
cardiac surgery. Our analysis was limited to isolated mitral
valve disease, and reoperative cases were excluded. Also,
although there were no significant differences in baseline
risk, the relative proportion of patients with chronic obstruc-
tive pulmonary disease in the sternotomy group was higher.
Second, although data on postoperative functional status
were standardized on computer order-entry forms and alldiovascular Surgery c Volume 143, Number 4S S89
Technical Considerations Iribarne et alcardiothoracic patients were evaluated by a physical thera-
pist with specialization in thoracic physical therapy, there
may have been variability in therapy provided. Such vari-
ability, however, would unlikely be biased toward either in-
cision type versus the other.
Third, although it is our institutional practice to perform
MIMVS through an incision that is generally between 6 and
8 cm, in some instances it is possible that the thoracotomy
incision may have been lengthened to improve exposure. In
addition, although a minithoracotomy approach was used in
this study, it should be noted that various less invasive inci-
sion types, such as a limited sternotomy, are used in practice
and may potentially achieve similar results because of de-
creased surgical trauma.
Fourth, although therewas no significant difference in the
rate of repairs between groups, data on specific repair tech-
niques were not available. These techniques may have influ-
enced operative times.
Finally, the results do not take into account the learning
curve associated with a minimally invasive approach and
the fact that the observed advantages in resource use and
functional status may not be achieved early in the learning
process. Importantly, most of the minimally invasive cases
were performed in the latter half of the study period, dem-
onstrating that such an approachmay not be readily applica-
ble to higher-risk elderly patients early in the learning curve.
CONCLUSIONS
Although the study results must be interpreted in the con-
text of the limitations cited here, we have demonstrated that
MIMVS is not inferior to the traditional sternotomy ap-
proach with regard to morbidity and mortality, although it
is associated with slightly increased crossclamp and CPBS90 The Journal of Thoracic and Cardiovascular Surgtimes. These increases in operative time are balanced, how-
ever, by the significant reduction in resource use and im-
provements in discharge disposition and inpatient
function status achieved with a minimally invasive ap-
proach. In light of the growing elderly population, MIMVS
represents an effective surgical approach for management
of mitral valve disease with the potential for significant re-
ductions in resource use.References
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